Proteomic and Metabolomic Approaches to Diagnose Diabetes and Pre-Diabetes

The summary for the Proteomic and Metabolomic Approaches to Diagnose Diabetes and Pre-Diabetes grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Proteomic and Metabolomic Approaches to Diagnose Diabetes and Pre-Diabetes: Over 5 million adults in the U.S. have undiagnosed type 2 diabetes, and another 38 million with pre-diabetes are at increased risk for developing diabetes. The lack of a simple and reliable way to detect diabetes and pre- diabetes has hindered identification of these individuals and provision of effective therapies. The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) encourages the application of proteomic and other novel technology to develop new diagnostic tests and/or to identify new biomarkers for the diagnosis of pre-diabetes and/or diabetes that do not require fasting or glucose administration.

Federal Grant Title:	Proteomic and Metabolomic Approaches to Diagnose Diabetes and Pre-Diabetes
Federal Agency Name:	National Institutes of Health
Grant Categories:	Health
Type of Opportunity:	Discretionary
Funding Opportunity Number:	PAR-04-076
Type of Funding:	Grant
CFDA Numbers:	93.847
CFDA Descriptions:	Diabetes, Endocrinology and Metabolism Research
Current Application Deadline:	No deadline provided
Original Application Deadline:	Multiple Receipt Dates - See Link to Full Announce
Posted Date:	Mar 23, 2004
Creation Date:	Aug 20, 2004
Archive Date:	Aug 20, 2004
Total Program Funding:
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching:	No

Applicants Eligible for this Grant: State governments County governments City or township governments Special district governments Independent school districts Public and State controlled institutions of higher education Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education For profit organizations other than small businesses Small businesses Others (see text field entitled "Additional Information on Eligibility" for clarification)
Link to Full Grant Announcement: Information not provided
Grant Announcement Contact: If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [email protected] NIH OER Webmaster
Similar Government Grants: • Limited Competition for the Continuation of Type 1 Diabetes in Acute Pancreatitis Consorti...; • Single Source for the Continuation of the Type 1 Diabetes in Acute Pancreatitis Consortium...; • Polycystic Kidney Disease Core Centers (U54 Clinical Trial Not Allowed); • Central Coordinating Site for the Polycystic Kidney Disease Research Core Centers (U24 Cli...; • Toward ElucidAting MechanismS of HIV Pathogenesis within the Mission of the NIDDK (Pathoge...; • Molecular Therapy Core Centers; • Pilot and Feasibility Program in Human Islet Biology; • Diabetes Endocrinology Research Centers
More Grants from the National Institutes of Health: • Organs-on-a-Chip in Dental, Oral, and Craniofacial Research (DOC-OoCs) (R21 Clinical Trial...; • Exploratory Studies to Investigate Mechanisms of HIV infection, Replication, Latency, and/...; • Organs-on-a-Chip in Dental, Oral, and Craniofacial Research (DOC-OoCs) (R01 Clinical Tri...; • Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed); • Basic Research in Cancer Health Disparities (R01 Clinical Trial Not Allowed)